Article Text

Download PDFPDF
CASE REPORT
The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney
  1. B Talbot1,
  2. D Wright2,
  3. K Basnayake1
  1. 1Department of Renal Medicine, Brighton and Sussex University Hospitals Trust, Brighton, East Sussex, UK
  2. 2Department of Histopathology, Brighton and Sussex University Hospitals, Brighton, East Sussex, UK
  1. Correspondence to Dr B Talbot, bentalbot{at}doctors.org.uk

Summary

Multiple myeloma (MM) is the second most common haematological malignancy in the UK. We present a case series of three patients with light chain only myeloma who had normal serum protein electrophoretic studies at screening and were diagnosed using serum and urine free light chain assessment. This series reiterates the importance of thorough and robust screening for MM in patients presenting with renal disease. We review the up to date literature and we highlight the need to screen patients for MM with a combination of serum electrophoresis/immunofixation and either urinary or serum free light chain measurement and to maintain a high index of suspicion regardless of the presence or absence of proteinuria. We also discuss the emerging role of the serum free light chain assay.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.